Cite

HARVARD Citation

    Marchetti, M. (2017). Cost-effectiveness of kinase inhibitors for hematologic malignancies: a systematic and critical review. Expert review of pharmacoeconomics & outcomes research. pp. 469-480. [Online]. 
  
Back to record